Advertisement

Topics

Companies Related to "Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes" [Most Relevant Company Matches] RSS

21:21 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Efficacy Study Umbilical Cord Placenta Derived Mesenchymal" Companies 1–25 of 2,500+

Extremely Relevant

Americord Registry

Americord Registry is the first cord blood bank to offer Cord Plus, or cryogenic placenta stem cell preservation. Americord focuses on the collection, processing, and storage of newborn stem cells from umbilical cord blood and the placenta for future medical or therapeutic use. Americord is registered with the FDA and the company's laboratory is accredited by the AABB. The company was founded in 2...


Americord Registry LLC

Americord Registry LLC is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008,...

ViaCell

ViaCell, Inc. is a biotechnology company dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord®, a product offering through which families can preserve their baby’s umbilical cord blood at the time of birth for possible future medical use in treating over 40 diseases including certain blood cancers and genetic diseases. ViaCell also conducts re...


Insception Biosciences Inc

Insception Biosciences Inc. is a Canadian company founded by Canadian scientists and physicians. We are the country's largest and most established cord blood bank. In 1996, we began as the Toronto Cord Blood Programme and operated out of Toronto General Hospital, and later Toronto's Mount Sinai Hospital.Dr. Robert Casper, Dr. Ian Rogers, and Dr. Barbara Cruickshank, all integral members of The To...

LifeSource Cryobank

LifeSource Cryobank is a Louisiana-owned and operated by health care professionals with a concerned interest in future stem cell regenerative and repair therapies. The company stores multiplied adult Mesenchymal stem cells and umbilical cord blood. LifeSource is located at 101 E. Fairway Drive, Suite 502, Covington, LA 70433. (985) 867-8902. www.lifesourcecryoban...

Relevant

Shenzhen Beike Biotechnology Company, Ltd.

Shenzhen Beike Biotechnology Co., Ltd. is China's leading biotechnology company focusing on the production of adult stem cells for use in medical therapies. Headquartered in Shenzhen (near Hong Kong) with a flagship regenerative medicine facility at the China Medical City in Jiangsu province, Beike produces a full line of stem cell products derived from umbilical cord, cord blood and autologou...

StemCyte, Inc.

StemCyte, Inc. is a leading, global umbilical cord blood ("UCB") stem cell transplantation and therapeutic products company. StemCyte, headquartered in Southern California has UCB storage facilities in both California and in Taiwan which collect, processes and stores UCB stem cells to be used as therapeutic treatments. Stem cells are used to replace or initiate the production of other cells that a...

Cord Blood America, Inc.

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing numbe...

AmStem Corporation

AmStem Inc. is a corporation registered in the State of Nevada with offices in San Francisco, California and Seoul, Korea. The company is a world leader in the area of stem cell research using stem cells derived from the umbilical cord immediately after birth. The company has 19 U.S. and international patents related to stem cell processing, application an...

Cord Blood America

Cord Blood America's mission is to be the most respected stem cell preservation company in the world. Cord Blood America will achieve its mission through educating expectant parents, families with a history of disease, critically ill patients, and all others who wish to learn about this life saving opportunity. We will provide constant care and support to the families whose stem cells we preserve,...

GeneCell International

GeneCell International, LLC is a trusted provider of collection, processing and storage of umbilical cord blood from which stem cells can be extracted to treat a variety of diseases and disorders. Headquartered in Miami, Florida and with local offices in Central Florida, Texas, Connecticut, Massachusetts, Rhode Island, the Dominican Republic, Panama, and V...

Cord Blood Registry

Cord Blood Registry® (CBR®) is the world's largest and most experienced stem cell bank. The company's primary focus is enabling parents to preserve the unique population of stem cells from their newborn's umbilical cord and to ensure the viability of the cells for medical use if needed by the child or immediate family member. During the last two decades, CBR has processed and stored cord bloo...

Reval

Be The Match is a movement that engages a growing community of people inspired to help patients who need a marrow or umbilical cord blood transplant. The National Marrow Donor Program (NMDP), a leader in the field of marrow and cord blood transplantation, created Be The Match to provide opportunities for the public to become involved in saving the lives of people with leukemia, lymphoma and other ...

Beike Biotech Company Limited

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company. Its scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's unique processing technologies prepare the cells for u...

Shenzhen Beike Biotechnology Co. Ltd.

Beike Biotechnology ( http://www.beikebiotech.com ) is China's leading biotechnology company. Its scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's unique processing technologies prepare the cells for ...

AuxoCell Laboratories, Inc.

AuxoCell Laboratories, Inc. (AuxoCell) is a leading stem cell therapeutic and regenerative medicine company located in Massachusetts. AuxoCell's primary research focus is to develop the enormous therapeutic potential of the primitive stem cells found in the Wharton's Jelly of the human umbilical cord. With exclusive patent rights and proprietary processing...

TheraCoat

TheraCoat is a specialty pharmaceutical company founded in 2004 by uro-oncologists and biomaterial specialists. TheraCoat’s Board of Directors and Scientific Advisory Board feature renowned scientific experts in the fields of urology, pharma top executives and experienced business veterans; among them Prof. Belldegrun and Mr. Hurvitz, both TEVA Board ...

Viacord

Being the leader in the cord blood banking and research and development industry means providing the highest quality service, care and science. Since 1993 our dedication to care, and attention to every detail, has made ViaCord a leader in cord blood preservation. Along with our parent company ViaCell we continue to set the standards of cord blood preservation and to research new, life-saving appli...

Beike Biotechnology Company Limited

Beike Biotechnology (http://www.beikebiotech.com) is Asia's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell ther...

Shenzhen Beike Biotechnology Co., Ltd.

Shenzhen Beike Biotechnology Co., Ltd. ("Beike") is China's leading biotechnology company whose scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of adult stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell therapies are administered by physician...

Beike Biotechnology Co. Ltd.

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell th...

The National Marrow Donor Program

The National Marrow Donor Program (NMDP) is the global leader in providing marrow and umbilical cord blood transplants to patients with leukemia, lymphoma and other diseases. The nonprofit organization matches patients with donors, educates health care professionals and conducts research so more lives can be saved. The NMDP also operates Be The Match®, ...

China Cord Blood Corporation

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only six licenses have been issued as of today. China Cord Bl...

Pluristem Therapeutics Inc.

Pluristem is a clinical stage biotechnology company with patented technology for the development and manufacturing of standardized cell therapies derived from the human placenta. Pluristem’s proprietary and scalable PLX (PLacental eXpanded) cell product candidates are developed as readily available for the treatment of critical limb ischemia (CLI) and...

National Marrow Donor Program

As a leader in the field of unrelated marrow and umbilical cord blood transplantation, the National Marrow Donor Program (NMDP) is dedicated to ensuring all patients who need a transplant receive access to this potentially life-saving treatment. Headquartered in Minneapolis, the nonprofit organization has been entrusted by the federal government through th...


More From BioPortfolio on "Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks